Loading...
NPI 1770621161 · Carmel, IN · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
American Health Network Of Indiana, LLC is a clinical medical laboratory provider located in Carmel, Indiana. This profile covers 86 Medicare and 88 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | American Health Network Of Indiana, LLC |
| Address | 13000 N Meridian St Ste 100 |
| City | Carmel |
| State | IN |
| ZIP | 46032 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | February 1, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.2M |
| Medicaid | $1.6M |
AMERICAN HEALTH NETWORK OF INDIANA, LLC operates as a Clinical Medical Laboratory whose Medicare top revenue drivers are routine outpatient panels: 80061 ($323K, 15.3% of Medicare revenue), 80053 ($293.7K, 14.0%), and 84443 ($274.4K, 13.0%). These three codes together account for 42.3% of the provider's total Medicare revenue, indicating the business is largely built around high-volume lipid, metabolic and TSH testing rather than specialized procedural services.
On the Medicaid side the revenue mix emphasizes broad screening and high-throughput testing: 80050 ($396.5K, 26.3%), 80061 ($160.3K, 10.6%), and U0003 ($141.8K, 9.4%) are the top three codes and together account for 46.4% of the provider’s total Medicaid revenue. The presence of U0003 at $141.8K shows a material contribution from high-throughput SARS‑CoV‑2 PCR testing in the Medicaid population alongside comprehensive health panels.
The practice demonstrates clear revenue concentration: the precomputed shares show the top three Medicare codes make up 42.3% of Medicare revenue while the top three Medicaid codes make up 46.4% of Medicaid revenue. This concentration suggests the provider’s financial performance is sensitive to utilization and reimbursement changes for a relatively small set of panels (80061, 80053, 84443 on Medicare; 80050, 80061, U0003 on Medicaid).
Payer mix is diversified but Medicare is larger in scale: the provider reported Total Medicare revenue of $2.2M and Total Medicaid revenue of $1.6M. Both payers are meaningful to the operation — Medicare represents the larger single source on file, while Medicaid contributes significant volume particularly for the general health panel (80050) and pandemic-era testing (U0003).
National competitive standing on Medicare is elevated for several routine assays: 80061 ranks #82 of 21671 (100th percentile; notably above typical national volume), 80053 ranks #100 of 26416 (100th percentile; notably above typical national volume), and 83036 ranks #82 of 44997 (100th percentile; notably above typical national volume). In aggregate these high ranks imply the lab is a high-volume national player for common outpatient chemistry and diabetes monitoring tests.
Within Indiana the provider holds a strong in‑state position for key Medicaid panels: 80050 ranks #4 of 83 in-state (96th percentile; notably above typical state volume), 80061 ranks #5 of 220 (98th percentile; notably above typical state volume), and 83036 ranks #5 of 361 (99th percentile; notably above typical state volume). These ranks indicate the lab is a leading supplier of general health panels and A1C testing in-state.
The provider’s service mix includes both routine clinical testing and substance-testing capabilities: Medicare shows meaningful revenue for definitive drug testing codes G0481 ($28.5K, 76th percentile) and G0480 ($27.6K, 78th percentile), while Medicaid activity includes 80307 presumptive drug testing ($119.1K, 76th percentile) and G0480/G0481 definitive tests. This combination indicates operations capable of both high-volume diagnostic screening and confirmatory toxicology services.
The entity has an established tenure in the marketplace with its NPI enumerated on 2007-02-01 (~19 years ago), which, together with high-percentile ranks across many routine codes, suggests a sustained, operationally mature laboratory footprint focused on high-volume outpatient testing for both Medicare and Medicaid populations.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
86 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 24,850 | $10 | $323K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 29,370 | $10 | $293.7K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 17,150 | $20 | $274.4K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 7,320 | $30 | $212.2K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 18,720 | $10 | $187.2K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 23,250 | $10 | $186K |
| 82607 | The lab analyst performs a test to measure the amount of vitamin B12 in a patient specimen, typically in patient blood. | 4,920 | $20 | $73.8K |
| 83970 | Parathyroid hormone test measures the level of PTH in the blood. This test is done to ascertain the level of calcium and evaluate the parathyroid function. | 1,790 | $40 | $71.6K |
| 84439 | The lab analyst performs a test to measure free thyroxine, or free T4, typically in patient serum. | 6,050 | $10 | $54.5K |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 2,800 | $20 | $53.2K |
Showing 1–10 of 86
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 86 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
88 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 9,910 | $40 | $396.5K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 26,720 | $10 | $160.3K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 2,680 | $50 | $141.8K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 9,160 | $10 | $128.2K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 5,180 | $20 | $119.1K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 21,740 | $1 | $87K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 25,290 | $1 | $75.9K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 13,850 | $1 | $55.4K |
| 82607 | The lab analyst performs a test to measure the amount of vitamin B12 in a patient specimen, typically in patient blood. | 6,640 | $10 | $46.5K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 20,080 | $1 | $40.2K |
Showing 1–10 of 88
How this provider's Medicaid billing volume and revenue compare to other Indiana providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Indiana median
88 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 17 | 20 | 1,610 | $70 | $841.6K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 13 | 30 | 400 | $90 | $443.4K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 47 | 190 | 800 | $40 | $344.7K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 26 | 90 | 1,150 | $60 | $289.6K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 9 | 20 | 1,160 | $50 | $236.5K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 32 | 90 | 390 | $40 | $171.1K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 4 | 80 | 340 | $70 | $139.8K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 62 | 110 | 490 | $30 | $88.4K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 63 | 110 | 520 | $20 | $87.5K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 44 | 210 | 5,200 | $10 | $83.7K |
Showing 1–10 of 88
Other providers in the same ZIP code as American Health Network Of Indiana, LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.